Crossmark

Long-term effect of combined therapy with somatostatin analogs and dopamine agonists as a primary treatment in a non-functioning invasive pituitary macroadenoma

Crossref DOI link: https://doi.org/10.1016/j.endien.2021.10.008

Published Print: 2021-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Iglesias, Pedro

Cardona, Jorge

Díez, Juan J.
License Information

Text and Data Mining valid from 2021-06-01
More Information

This article is maintained by: Elsevier

Article Title: Long-term effect of combined therapy with somatostatin analogs and dopamine agonists as a primary treatment in a non-functioning invasive pituitary macroadenoma

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2021.10.008

Content Type: simple-article

Copyright: © 2020 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below